Chemical Compound Review:
Kvaterin 3-(trimethylammonioamino) propanoate
Synonyms:
Quaterin, Meldomiun, Meldonium, Mildronate, MET88, ...
This record was replaced with 123869.
- Mildronate, an inhibitor of carnitine biosynthesis, induces an increase in gamma-butyrobetaine contents and cardioprotection in isolated rat heart infarction. Liepinsh, E., Vilskersts, R., Loca, D., Kirjanova, O., Pugovichs, O., Kalvinsh, I., Dambrova, M. J. Cardiovasc. Pharmacol. (2006)
- Mildronate, a novel fatty acid oxidation inhibitor and antianginal agent, reduces myocardial infarct size without affecting hemodynamics. Sesti, C., Simkhovich, B.Z., Kalvinsh, I., Kloner, R.A. J. Cardiovasc. Pharmacol. (2006)
- Mildronate: cardioprotective action through carnitine-lowering effect. Dambrova, M., Liepinsh, E., Kalvinsh, I. Trends Cardiovasc. Med. (2002)
- Carnitine transport into muscular cells. Inhibition of transport and cell growth by mildronate. Georges, B., Le Borgne, F., Galland, S., Isoir, M., Ecosse, D., Grand-Jean, F., Demarquoy, J. Biochem. Pharmacol. (2000)
- Endothelium- and nitric oxide-dependent vasorelaxing activities of gamma-butyrobetaine esters: possible link to the antiischemic activities of mildronate. Sjakste, N., Kleschyov, A.L., Boucher, J.L., Baumane, L., Dzintare, M., Meirena, D., Sjakste, J., Sydow, K., Münzel, T., Kalvinsh, I. Eur. J. Pharmacol. (2004)
- Carnitine depletion in rat pups from mothers given mildronate: a model of carnitine deficiency in late fetal and neonatal life. Peschechera, A., Scalibastri, M., Russo, F., Giarrizzo, M.G., Carminati, P., Giannessi, F., Arduini, A., Ricciolini, R. Life Sci. (2005)
- Fatty acid oxidation and related gene expression in heart depleted of carnitine by mildronate treatment in the rat. Degrace, P., Demizieux, L., Gresti, J., Tsoko, M., André, A., Demaison, L., Clouet, P. Mol. Cell. Biochem. (2004)
- Mildronate: an antiischemic drug for neurological indications. Sjakste, N., Gutcaits, A., Kalvinsh, I. CNS drug reviews. (2005)
- Protection of azidothymidine-induced cardiopathology in mice by mildronate, a mitochondria-targeted drug. Klusa, V., Pupure, J., Isajevs, S., Rumaks, J., Gordjushina, V., Kratovska, A., Taivans, I., Svirskis, S., Viksna, L., Kalvinsh, I. Basic & clinical pharmacology & toxicology. (2006)
- Effects of gamma-butyrobetaine and mildronate on nitric oxide production in lipopolysaccharide-treated rats. Sjakste, N., Baumane, L., Boucher, J.L., Dzintare, M., Meirena, D., Sjakste, J., Lauberte, L., Kalvinsh, I. Basic & clinical pharmacology & toxicology. (2004)
- HPLC analysis of mildronate and its analogues in plasma. Sahartova, O., Shatz, V., Kalvins, I. Journal of pharmaceutical and biomedical analysis. (1993)
- Direct chronotropic and inotropic effects of mildronate using cross-circulated dog atrial and ventricular preparations. Chiba, S., Akahane, K., Furukawa, Y., Karasawa, Y. Japanese heart journal. (1989)